Charles Schwab’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.5M | Sell |
1,291,671
-169,046
| -12% | -$3.6M | ﹤0.01% | 1487 |
|
|
2025
Q1 | $28.2M | Sell |
1,460,717
-24,355
| -2% | -$470K | 0.01% | 1434 |
|
|
2024
Q4 | $26.5M | Buy |
1,485,072
+52,359
| +4% | +$934K | ﹤0.01% | 1542 |
|
|
2024
Q3 | $31.4M | Buy |
1,432,713
+497,984
| +53% | +$10.9M | 0.01% | 1436 |
|
|
2024
Q2 | $7.29M | Sell |
934,729
-81,816
| -8% | -$638K | ﹤0.01% | 2186 |
|
|
2024
Q1 | $4.21M | Buy |
1,016,545
+62,699
| +7% | +$260K | ﹤0.01% | 2341 |
|
|
2023
Q4 | $2.49M | Buy |
953,846
+13,050
| +1% | +$34.1K | ﹤0.01% | 2546 |
|
|
2023
Q3 | $1.76M | Buy |
940,796
+629,726
| +202% | +$1.18M | ﹤0.01% | 2637 |
|
|
2023
Q2 | $781K | Buy |
311,070
+296,489
| +2,033% | +$744K | ﹤0.01% | 2850 |
|
|
2023
Q1 | $25.5K | Sell |
14,581
-531
| -4% | -$929 | ﹤0.01% | 3477 |
|
|
2022
Q4 | $64.2K | Buy |
+15,112
| New | +$64.2K | ﹤0.01% | 3312 |
|
|
2022
Q2 | – | Sell |
-61,313
| Closed | -$151K | – | 3632 |
|
|
2022
Q1 | $151K | Buy |
61,313
+6,280
| +11% | +$15.5K | ﹤0.01% | 3353 |
|
|
2021
Q4 | $149K | Hold |
55,033
| – | – | ﹤0.01% | 3401 |
|
|
2021
Q3 | $276K | Buy |
55,033
+7,385
| +15% | +$37K | ﹤0.01% | 3283 |
|
|
2021
Q2 | $356K | Buy |
+47,648
| New | +$356K | ﹤0.01% | 3216 |
|